C4 Therapeutics (CCCC) FCF Margin (2019 - 2026)
C4 Therapeutics' (CCCC) quarterly FCF Margin came in at 487.35% in Q1 2026, down 2749.0% year-on-year from 18.4% in Q1 2025, and down 136.23% quarter-over-quarter from 206.31% in Q4 2025.
C4 Therapeutics (CCCC) FCF Margin (2019 - 2026) Analysis & Trends
C4 Therapeutics' FCF Margin history runs 8 years deep, the most recent figure standing at 487.35% for Q1 2026.
- On a quarterly basis, FCF Margin fell 2749.0% year-over-year to 487.35% in Q1 2026; TTM through Mar 2026 was 275.37%, a 7302.0% decrease from a year earlier, with the FY2025 full-year figure at 276.24%, down 9263.0% from the prior year.
- FCF Margin slipped to 487.35% in Q1 2026 per CCCC's latest filing, from 206.31% in the prior quarter.
- Across five years, FCF Margin topped out at 41.54% in Q2 2024 and bottomed at 1072.81% in Q4 2022.
- The 5-year median for FCF Margin is 349.73% (2022), against an average of 438.8%.
- Across the five-year window, FCF Margin sank 94495 bps in 2022 and surged 68515 bps in 2024, its largest moves.
- Year by year, FCF Margin stood at 1072.81% in 2022, then surged by 31 bps to 741.06% in 2023, then jumped by 53 bps to 346.3% in 2024, then jumped by 40 bps to 206.31% in 2025, then slumped by 136 bps to 487.35% in 2026.
- Per Business Quant, the three latest CCCC FCF Margin figures stand at 487.35% (Q1 2026), 206.31% (Q4 2025), and 276.46% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | C4 Therapeutics | 460.17 Mn | 224.50 Mn | - | -487.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -487.35% |
| Dec 31, 2025 | -206.31% |
| Sep 30, 2025 | -276.46% |
| Jun 30, 2025 | -189.42% |
| Mar 31, 2025 | -459.86% |
| Dec 31, 2024 | -346.30% |
| Sep 30, 2024 | -158.21% |
| Jun 30, 2024 | -41.54% |
| Mar 31, 2024 | -596.18% |
| Dec 31, 2023 | -741.06% |
| Sep 30, 2023 | -282.76% |
| Jun 30, 2023 | -726.69% |
| Mar 31, 2023 | -896.89% |
| Dec 31, 2022 | -1,072.81% |
| Sep 30, 2022 | -463.80% |
| Jun 30, 2022 | -164.26% |
| Mar 31, 2022 | -349.73% |
| Dec 31, 2021 | -127.86% |
| Sep 30, 2021 | -202.24% |
| Jun 30, 2021 | -188.61% |